Role of imbalance between neutrophil elastase and α1-antitrypsin in cancer development and progression
- 1 March 2004
- journal article
- review article
- Published by Elsevier in The Lancet Oncology
- Vol. 5 (3) , 182-190
- https://doi.org/10.1016/s1470-2045(04)01414-7
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Paternal mosaicism proves the pathogenic nature of mutations in neutrophil elastase in severe congenital neutropeniaBlood, 2002
- TNF-R1 Signaling: A Beautiful PathwayScience, 2002
- Leukocyte Elastase Negatively Regulates Stromal Cell-derived Factor-1 (SDF-1)/CXCR4 Binding and Functions by Amino-terminal Processing of SDF-1 and CXCR4Journal of Biological Chemistry, 2002
- Lung cancer risk in families of nonsmoking probands: Heterogeneity by age at diagnosisGenetic Epidemiology, 1999
- cJun overexpression in MCF-7 breast cancer cells produces a tumorigenic, invasive and hormone resistant phenotypeOncogene, 1999
- Prevalence of hepatocellular carcinoma in alpha-1-antitrypsin deficiencyJournal of Hepatology, 1994
- Enhancer Function of a 53-bp Repetitive Element in the 5′ Flanking Region of the Human Neutrophil Elastase GeneBiochemical and Biophysical Research Communications, 1994
- Activation of matrix metalloproteinase 3 (stromelysin) and matrix metalloproteinase 2 (‘gelatinase’) by human neutrophil elastase and cathepsin GFEBS Letters, 1989
- Risk of Cirrhosis and Primary Liver Cancer in Alpha1-Antitrypsin DeficiencyNew England Journal of Medicine, 1986
- Distribution of α1-Antitrypsin Variants in a US White PopulationHuman Heredity, 1983